Patents by Inventor Matthias Karl Dietrich Wiendahl

Matthias Karl Dietrich Wiendahl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of purifying pegylated proteins
    Patent number: 8697844
    Abstract: The invention relates to a method of purifying PEGylated proteins by removing impurities from samples containing PEGylated proteins, in particular, but not exclusively vitamin K-dependent blood coagulation factors such as Factor IX (FIX), to proteins purified by said method and to the use of said purified proteins in therapy, in particular but not exclusively, for the treatment of diseases alleviated by blood coagulation factors such as the prophylactic treatment of hemophilia.
    Type: Grant
    Filed: November 24, 2010
    Date of Patent: April 15, 2014
    Assignee: Novo Nordisk A/S
    Inventors: Matthias Karl Dietrich Wiendahl, Lars Sejersgaard, Are Bogsnes
  • Method of Purifying Pegylated Proteins
    Publication number: 20120244137
    Abstract: The invention relates to a method of purifying PEGylated proteins by removing impurities from samples containing PEGylated proteins, in particular, but not exclusively vitamin K-dependent blood coagulation factors such as Factor IX (FIX), to proteins purified by said method and to the use of said purified proteins in therapy, in particular but not exclusively, for the treatment of diseases alleviated by blood coagulation factors such as the prophylactic treatment of hemophilia.
    Type: Application
    Filed: November 24, 2010
    Publication date: September 27, 2012
    Applicant: NOVO NORDISK HEALTH CARE AG
    Inventors: Matthias Karl Dietrich Wiendahl, Lars Sejersgaard, Are Bogsnes